Belgium OBJECTIVES: The objective was to develop the Self-Injection Assessment Questionnaire © (SIAQ © Version 1) as a comprehensive instrument for use across diseases to assess the perceived advantages of self-injection (SI) and the potential limitations of SI-specifically, psychological, social or physical limitations. METHODS: The SIAQ © was developed following four steps: 1) in-depth face-to-face interviews involving focus groups with rheumatoid arthritis or Crohn's disease (two conditions characterised by different symptoms and physical limitations); 2) qualitative analysis and development of a conceptual model to illustrate the domains relevant to patients; 3) questionnaire item generation in US English using patients' verbatim; and 4) cognitive debriefing interviews to evaluate content validity. RESULTS: Perceived advantages of SI were: convenient treatment scheduling, feeling in control of the disease, few side-effects and high efficacy of the medication. In addition, some patients expressed psychological limitations (fear of needles, fear of pain, fear of self-injecting, lack of self-confidence in performing injections properly), physical limitations (device handling problems), social limitations (embarrassed 'to use needles'), and storage problems. Thirty-three items were generated and tested during cognitive debriefing interviews. The final questionnaire (SIAQ © Version 1) is composed of 23 items grouped into six domains, which assess psychological limitations about injections in general; psychosocial limitations about SI in particular; physical limitations about pain and skin reactions; physical limitations about the usability of the SI device; convenience and satisfaction with SI; and willingness to continue SI. CONCLUSION: The SIAQ © can be used to assess the perceived advantages of SI (convenience and satisfaction) and the potential limitations of SI-specifically, psychological (fear of injections), social (acceptability) or physical aspects (usability and injection-site reactions such as pain) and willingness to continue SI in the future. The psychometric properties of the SIAQ © will be evaluated in clinical studies.
PMC25 USING DISCRETE CHOICE EXPERIMENT MODELLING TO ASSESS PREFERENCES FOR HEALTH CARE CHARACTERISTICS
Taylor MJ 1 , Cisse S 2 1 University of York, York, UK, 2 York Health Economics Consortium, York, UK OBJECTIVES: Health Care Systems consists of a large number of characteristics. However the scarcity of resources restricts the implementation of some policies although they would certainly contribute to improve the population health. This implies that improvement in a particular domain of the health care system leads to some sacrifices in other areas. Then, the public is asked to weigh the feature of the Health Care System and make-trade offs between attributes they consider important. For instance how much additional tax the public is prepared to accept for a decrease in waiting times for surgery. This study intends to use the Discrete Choice Experiment to assess the benefits in these characteristics. METHODS: The different attributes of the Health Care System are identified using a literature search. This serves as a basis for the construction of a binary outcome questionnaire across 27 pairwise choices. A sample of 50 persons was interviewed in the area surrounding York University. The logit model has been used for the analysis, which assesses the public's preference towards different attributes. RESULTS: The outcomes were in line with prior expectations. There was internal constancy in the result and those were statically significant. A main factor for the public's valuation was the number of people who would miss out on treatment due to cost. They were also much more concerned about the Infant mortality than Life expectancy. Furthermore the willingness to pay was estimated for each attribute. CONCLUSION: This experiment has demonstrated that the Discrete Choice Experiment could inform the decision makers about the public's preferences for attributes within the Health care System. Further, it will allow health care decision makers to more accurately compare the performance of different countries, accounting for the individual preferences of each population. Various simulations were carried out with different samples which had the same mean value in the EQ-5D tariff, but different percentage of subjects who achieved the best score (1 point) after an intervention. It was understood that the intervention produced an improvement of 1 point in one of the EQ-5D dimensions, and that benefit was present in all subjects. RESULTS: Different samples obtained different values in the EQ-5D after intervention depending on the percentage of subjects who achieved the best value in all the EQ-5D dimensions. Maximum differences were of 0.15 points, which is a value higher than that considered clinically relevant for the EQ-5D. CONCLUSION: An improvement in an utility index associated to an intervention could depend on the characteristics of the studied sample and this do not seem adequate or desirable. Although an intervention is equally effective in various samples, the results are not the same and this could be a serious handicap for the utility index. Other methods to calculate utility index values must be developed in order to better evaluate the changes associated to an intervention. 
PMC26 UTILITY INDEX CALCULATION: SIMULATION STUDY CONSIDERING THE HEALTH STATUS AFTER AN INTERVENTION
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